FIGURE 2.

Discriminative capacities of factors associated with hepatic severe adverse events during Obeticholic acid treatment. Results are shown as area under the receiver operating characteristic, 95% confidence intervals and p‐values. Only predictors showing AUROC >0.70 are reported in the plot.